Core Insights - Sonova Group has opened a subsidiary in the Boao Lecheng International Medical Tourism Pilot Zone, enhancing access to advanced hearing technology for hearing-impaired patients in China [1][2] - The Lecheng Pilot Zone is recognized as a "medical special zone" in China, facilitating the entry of international innovative medical devices and drugs [1] - Sonova has previously leveraged Lecheng's policies to introduce the Ultra 3D cochlear implant, which has benefited numerous patients since its approval [2] Group 1 - The new subsidiary aims to integrate resources with local hospitals to create innovative hearing health service models, ensuring advanced technologies reach patients efficiently [1] - The Marvel M30 cochlear implant technology has been rapidly introduced in China, completing over 300 clinical applications within a few months [1] - Lecheng has introduced 498 types of urgently needed medical devices and drugs that are available internationally but not yet in China, with over 30 medical institutions operational [2] Group 2 - Sonova's strategy is to utilize the Hainan Free Trade Port's policy advantages to expedite the delivery of cutting-edge hearing solutions to Chinese users [2] - The management of the Lecheng Pilot Zone anticipates that companies will leverage their technological strengths and the zone's policy benefits to accelerate the development of high-end hearing device manufacturing and application [2]